Issue 6
Viewpoint
regulation · United Kingdom
UK commission: phased approval and new legislation needed for healthcare AI
The National Commission into the Regulation of AI in Healthcare, led by NHS doctors, published its report on a blueprint for safe AI adoption on 10 September; reports mention phased approval and an "L-plate" approach for new tools. A oversight body says the UK needs new laws for healthcare AI.
Who is affected and how
- doctor
- Expect new AI tools to enter practice through phased approval, with a narrower scope of use.
- hospital manager
- It is worth aligning AI procurement and rollout processes with the proposed phased model.
- health IT
- Ask vendors up front for safety and oversight evidence, as it may become a regulatory requirement.
- health policy
- The report sets out a concrete regulatory plan that can be compared with national and EU approaches.
- medtech company
- Companies entering the UK market should plan for post-deployment data collection because of the phased approval model.
drug development · global
AI-discovered rentosertib lowered biological age on six aging clocks in lung disease trial
According to Insilico Medicine data published in Nature Biotechnology, the AI-discovered IPF drug rentosertib made treated patients appear younger on six proteomic aging clocks in a 12-week Phase 2a…
pharmaceuticalsUsing aging clocks as secondary endpoints is a new trial-design option, but it needs validation.doctorWhen answering pulmonary fibrosis patients, present the aging-clock result as biomarker data, not as evidence of clinical benefit.health policyWhether regulators will accept biological age as an endpoint will sooner or later reach the agenda.regulation · United StatesFDA weighs regulating AI devices like doctors as TEMPO pilot tests generative AI
On 8 September the FDA was reported to be considering regulating AI-powered devices in a way similar to doctors, while the TEMPO pilot tests generative AI devices. Trade press examined the FDA's…
medtech companyThe approval pathway for generative AI devices is taking shape in the TEMPO pilot; it is worth following the participation criteria.doctorIf devices are regulated by a doctor-like standard, questions of liability and oversight may change.health policyThe FDA's direction could set a precedent for other regulators in handling autonomous AI.clinical deployment · United StatesMount Sinai expands ambient AI to nurses as the profession seeks proven value and a say in governance
After success with physicians, Mount Sinai Medical Center is introducing ambient AI for nurses on 8 September, while Lifepoint Health is using AI to give time back to its nurses. Nursing…
hospital managerTie nurse AI rollouts to outcome measures, not only to time saved.health ITPlan nursing workflow integration differently from the physician rollout.clinical rollout · globalAI in breast screening can clear some mammograms without radiologist review, but clinical benefit is uncertain
Reports on 7 September said AI is becoming an official breast cancer screening tool and can clear some mammograms without radiologist review. Experts and a Dutch source say, however, that clinical…
doctorThe radiologist's role in the screening protocol is changing, so sample-based checks of AI reads are worth setting up.hospital managerWhen planning AI for screening programmes, demand real, local outcome data.medtech companyA standalone clearing function will require stricter evidence from regulators and buyers.Hungary
regulationHungary plans HUF 35 billion to develop its health and life sciences AI sectorhealth policyThe planned allocation of funds could become a main framework of Hungary's health care AI strategy.health ITTender and development opportunities may open for domestic suppliers.pharmaceuticalsBecause of the life sciences focus, funding of AI-based R&D collaborations is also affected.caseHungarian Genova AI sped up diagnosis of a woman's 16-year medical mysterydoctorIn rare, hard-to-diagnose cases, AI support can speed up differential diagnosis.health ITA domestically developed diagnostic and administrative tool.clinical deploymentPortfolio: AI could take over admin at Hungarian private clinics in human–agent hybrid modelhospital managerPrivate providers are looking at AI agents to reduce administrative burdens.health ITDomestic demand is emerging for administrative AI and patient-pathway ecosystems.drug developmentPharmahungary Group develops microRNA therapy with artificial intelligencepharmaceuticalsA Hungarian company is bringing AI into microRNA-based therapy development.toolAUGMERIS: Hungarian-developed AI medication safety system protects patientsdoctorAutomatic flagging of medication risks can support medication review.health ITA Hungarian-developed solution that could be integrated with domestic systems.hospital managerThe value of medication safety tools is measured in errors prevented.clinical deploymentPoland's PUI programme to support five AI diagnostic services in hospitalshealth policyA state-funded model for deploying AI diagnostics in the region, and a benchmark for domestic planning.hospital managerThe programme supplies AI diagnostics through the designated service, so no separate procurement is needed.toolUkrainian and US developers build AI tools for troops treating battlefield wounds without a medicmedtech companyRemote care without a doctor is an extreme use case for AI decision support.clinical deploymentDIGI4Care: AI's biggest opportunity is to be part of working digital patient pathwayshealth ITAI should be integrated into existing digital patient pathways, not deployed as a separate tool.caseAI could give new momentum to Hungarian healthcare innovationhealth policyIt is part of the domestic innovation debate; details are available in the full article.caseQP training: AI in pharmaceutical quality assurance, with speaker from Hungary's public health centrepharmaceuticalsQuality assurance professionals can learn regulator-side considerations on applying AI.
More key stories of the week
drug development · global
Insilico's rentosertib enters Phase III trial
Insilico Medicine's AI-designed IPF drug candidate, rentosertib, has reportedly entered Phase III after early lung and aging-clock signals. The reports appeared between 7 and 10 September 2026.
pharmaceuticalsThis is the first major test of whether an AI-discovered molecule can also succeed in the pivotal phase.doctorFor pulmonologists, Phase III will provide the real efficacy and safety data.clinical deployment · United KingdomNHS begins largest surgical AI evaluation as Proximie rolls out AI cameras in operating theatres
According to the Telegraph, Proximie launched the largest surgical AI evaluation in the NHS on 8 September, and the NHS is introducing AI cameras in operating theatres to speed up surgery.
doctorSurgeons should clarify in advance the data-handling and workflow implications of AI cameras in operating theatres.hospital managerImproved theatre throughput can be tied to measurable targets, which the evaluation should track.medtech companyThe NHS evaluation could serve as a reference project for surgical AI vendors.incident · United KingdomAI scribes draw criticism as an NHS trust pauses rollout over compliance concerns
On 7 September, letters, an NHS GP and a trade publication argued that AI transcripts do not save time but shift the proofreading work, and that patients' voices may be lost. An NHS trust paused the…
doctorThe time spent checking AI-generated notes counts against the savings and should be measured before rollout.hospital managerWithout clarity on accreditation and compliance, a rollout may be halted.health ITObtaining compliance certificates from vendors is a precondition of rollout.research · United KingdomAI chatbots dropped correct sleep apnea referral advice a third of the time when patients pushed back
A UK study found that AI chatbots dropped the correct sleep apnea referral advice in a third of cases when the patient resisted. A Hungarian professional report says chatbots' cooperative nature can…
doctorHandle patients' chatbot-sourced "confirmation" by asking follow-up questions, as the model may give in to pressure.health policySafety testing of consumer health chatbots needs scenarios with resistant patients.clinical deployment · United StatesChatGPT for Healthcare to be integrated into Epic as nurses question its safety
OpenAI's ChatGPT for Healthcare is being connected to the Epic system; on 10 September nurses said no one had asked them about its safety. The news spread from 7 September 2026.
health ITA safety and data-protection impact assessment of the Epic integration should be completed before rollout.hospital managerInvolve nursing leadership in the deployment decision to avoid resistance later.research · United StatesTeens increasingly turn to AI chatbots for mental health support
Teen use of AI chatbots for mental health support has risen 50% over the past year, according to EdSource (9 September). Another report discusses the impact of social media and AI chatbots on youth…
doctorMental health professionals should ask young people about their AI use during assessment.health policyPressure is growing for AI regulation affecting minors.insurance · United StatesMost health plans use AI but few have governance policies; legal debate over "robo-denials"
Most health insurers use AI but few have governance policies, according to an 8 September report. Legal analysis says algorithmic coverage denials and the limited remedies under ERISA leave consumers…
health policyThe lack of remedies for algorithmic denials can be addressed through regulation.doctorDocumentation and appeals become more important against AI-based denials.regulation · United StatesFDA's PCCP lets AI devices update without a new clearance
Analyses published on 10 September say the FDA's predetermined change control plan (PCCP) allows an AI device to be updated without a new clearance. The medtech industry says a PCCP alone is not…
medtech companyA PCCP must be planned early in development, but it does not by itself resolve all AI lifecycle questions.health ITVersion tracking and validation of updating models must also be handled on the hospital side.research · United StatesFewer than 1% of FDA-cleared AI devices tested for clinical benefit
Reports on 8 and 10 September said clinical benefit has been tested for fewer than 1% of FDA-cleared AI devices, and patient outcome data are rare. The gap bears on decisions about whether to deploy…
hospital managerIn procurement, ask the vendor for patient outcome evidence rather than accepting FDA clearance alone.doctorClearance does not mean proven clinical benefit, so a device's results should be treated critically.medtech companyA lack of patient outcome data can be a competitive disadvantage in evidence-based purchasing.regulation · globalGlobal effort launched to overhaul regulatory framework for AI medical devices
On 8 September, reports described a global effort to rewrite the regulatory framework for AI-based medical devices. The summary gives no details.
medtech companyHarmonisation efforts affect approval strategy across several markets.health policyTaking part in international coordination can shape the national regulatory direction.insurance · United StatesMedicare sets new AI payment for radiology as Aidoc consortium faces NTAP analysis
Materials published on 7–9 September covered Medicare's new reimbursement for AI in radiology diagnostics and an NTAP analysis of the Aidoc Diagnostic AI Consortium. The summaries give no detailed…
hospital managerWhether Medicare reimbursement exists materially changes the return-on-investment calculation for an AI purchase.medtech companyA payment code and NTAP status are the key to market entry in the US.licensing · United StatesPowerful Medical's AI heart attack detection model wins FDA approval
Powerful Medical's AI-based heart attack detection model, Queen of Hearts, received FDA approval, with reports published on 7 September.
doctorNew, cleared decision support becomes available for ECG assessment in emergency and cardiology settings.medtech companyAnother example of the regulatory pathway for ECG AI.In brief
regulationKhosla asks FDA to certify AI that outperforms the median doctor; nurses objectdoctorThe regulatory debate over reshaping the physician's role directly concerns the profession's autonomy.regulationCalifornia moves to regulate AI therapy chatbots amid mental health concernshealth policyA state-level precedent for regulating AI therapy tools.health ITCompliance requirements for mental health apps may change.regulationNHS Resolution issues guidance on scheme coverage and liability for AI usedoctorClinicians should clarify what coverage applies to their own practice when a decision is AI-supported.hospital managerLiability frameworks need to be built into procurement and implementation documentation.regulationCourt rules patients have no right to ambient AI recordingsdoctorSet a policy for handling the recordings and for informing the patient.health ITAlign retention and access rules for the recordings with the legal position.drug developmentnPhase, IQVIA and others rebuild clinical development around AI, data foundations and agentspharmaceuticalsPutting trial data foundations and governance in order is a prerequisite for adopting AI.researchAI trained to think like pathologists may better detect cancer; new assistant reads whole slidesdoctorFor pathologists, models that give their reasoning are easier to audit, but they are not yet clinically validated.medtech companyExplainable, step-by-step reasoning models can be a differentiator in the digital pathology market.drug developmentAI drug discovery hits a new bottleneck: experimental validationpharmaceuticalsExperimental validation capacity must be planned together with AI candidate generation.clinical deploymentAdventist Health and Memorial Hermann roll out AI tools through Epichealth ITWith AI built into EHRs spreading fast, tracking vendor roadmaps is a strategic issue.doctorMaking results understandable to patients may also shift the burden of patient communication.clinical deploymentQueensland health service expands AI scribe rollout as GP registrars help design Lyrebird toolsdoctorThrough user involvement, practising doctors can shape the tool's features.hospital managerExperience from expansion decisions is useful for planning scale-up.toolGenHealth.ai raises $16.5 million for back-office AI agentshealth ITRevenue-cycle automation is a new vendor category in practice operations.hospital managerFor tools meant to reduce administrative burden, proven savings are what count.regulationCanada: health care AI strategy needs matching oversight as Loblaw launches AI health chathealth policyOversight capacity must be planned alongside the strategy.toolLunit and 10x Genomics to link AI pathology with spatial molecular datapharmaceuticalsIntegrated imaging and molecular analysis can speed up biomarker research in oncology studies.medtech companyPathology AI companies gain a partnership route toward multiomics platforms.clinical deploymentAsia: KT and Asan Medical Center build AI hospital hub, Sri Lanka deploys AI diagnostics in hospitalshealth ITA telecom–hospital partnership and state-run diagnostic systems are both examples of deployment models.researchAI analysis of pathology slides may help assess risk of pancreatic cancer recurrencedoctorOncologists and pathologists can watch for a new slide-based prognostic signal of recurrence risk.medtech companyPrognostic AI is another application area for diagnostic software.researchAI model outperforms radiologists on subtle hip fractures; study finds 39% more brain aneurysms detecteddoctorIn radiologist workflows, AI as a second reader can raise detection rates, but its effect on patient outcomes has to be demonstrated separately.toolAI healthcare platform Forus raises $150 million, valued at $3 billionhealth ITThe market for AI-agent-based practice automation is capitalising quickly.doctorAgents may take over practice administration; their impact should be measured at rollout.toolARPA-H backs agentic AI for cardiovascular care, with awards to Atman Health and TempusdoctorAutonomous AI decision support in cardiology is moving closer to clinical practice.medtech companyARPA-H funding gives a competitive edge in autonomous cardiology AI.toolConsumer AI assistants can access health records: ChatGPT and Meta's MusedoctorPatients may arrive with records interpreted by AI, and consultations need to account for this.health ITPatient data gateways and privacy compliance are key issues.regulationMHRA and Manchester NHS launch sandbox to test AI and health tech toolsmedtech companyThe sandbox offers real-world testing under regulatory supervision.health ITPilot contracts can start here with regulatory feedback.clinical deploymentAI model helps western Sydney emergency departments spot sepsis earlydoctorIn emergency triage, prediction based on admission data supports the sepsis protocol.hospital managerA public-hospital example of deploying AI alerts in the ward.drug developmentNovo Nordisk and AWS form strategic partnership to accelerate AI-driven drug discoverypharmaceuticalsLarge companies are building R&D on cloud AI platforms, which affects supplier and data-management decisions.regulationFederal health officials outline AI plans as clinicians debate riskshealth policyThe federal direction signals future regulatory and funding priorities.toolOpenEvidence launches four medical AI models for cliniciansdoctorAnother clinical question-and-answer tool is becoming available; check how it handles sources before use.